These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25077372)

  • 21. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
    Bettahi I; Zhang X; Afifi RE; BenMohamed L
    Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in herpes simplex virus immunobiology and vaccine research.
    Koelle DM; Corey L
    Clin Microbiol Rev; 2003 Jan; 16(1):96-113. PubMed ID: 12525427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity.
    Santana VC; Diniz MO; Cariri FA; Ventura AM; Cunha-Neto E; Almeida RR; Campos MA; Lima GK; Ferreira LC
    PLoS One; 2013; 8(8):e71322. PubMed ID: 23951135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology.
    Sandgren KJ; Truong NR; Smith JB; Bertram K; Cunningham AL
    Methods Mol Biol; 2020; 2060():31-56. PubMed ID: 31617171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?".
    Royer DJ; Carr DJJ
    J Virol; 2017 Dec; 91(23):. PubMed ID: 29138328
    [No Abstract]   [Full Text] [Related]  

  • 26. The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
    Kuo T; Wang C; Badakhshan T; Chilukuri S; BenMohamed L
    Vaccine; 2014 Nov; 32(50):6733-45. PubMed ID: 25446827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.
    Cremer KJ; Mackett M; Wohlenberg C; Notkins AL; Moss B
    Science; 1985 May; 228(4700):737-40. PubMed ID: 2986288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quest for a herpes simplex virus vaccine: background and recent developments.
    Hall MJ; Katrak K
    Vaccine; 1986 Sep; 4(3):138-50. PubMed ID: 3020819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
    Bourne N; Bravo FJ; Francotte M; Bernstein DI; Myers MG; Slaoui M; Stanberry LR
    J Infect Dis; 2003 Feb; 187(4):542-9. PubMed ID: 12599070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.
    Scriba M
    Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells.
    Ghasemi M; Erturk M; Buruk K; Sonmez M
    Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.
    Royer DJ; Carr MM; Chucair-Elliott AJ; Halford WP; Carr DJJ
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: objectives of herpes simplex virus vaccines seen from a historical perspective.
    Roizman B
    Rev Infect Dis; 1991; 13 Suppl 11():S892-4. PubMed ID: 1664123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential prophylactic and therapeutic vaccines for HSV infections.
    Ramachandran S; Kinchington PR
    Curr Pharm Des; 2007; 13(19):1965-73. PubMed ID: 17627530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and prospects for development of an HSV vaccine.
    Johnston C; Koelle DM; Wald A
    Vaccine; 2014 Mar; 32(14):1553-60. PubMed ID: 24016811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
    Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
    Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
    J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis.
    Naidu SK; Nabi R; Cheemarla NR; Stanfield BA; Rider PJ; Jambunathan N; Chouljenko VN; Carter R; Del Piero F; Langohr I; Kousoulas KG
    PLoS One; 2020; 15(2):e0228252. PubMed ID: 32027675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines for herpes simplex virus infections.
    Koelle DM
    Curr Opin Investig Drugs; 2006 Feb; 7(2):136-41. PubMed ID: 16499283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.